In this meta-analysis, we statistically synthesized findings from several eligible case-control studies involving the association between CCR5 Δ32 polymorphism and BC risk, and found no evidence for significant correlation between them in both the overall analysis and subgroup analyses according to ethnicity and control source. Here, CCR5 is linked to breast cancer.